Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sjogern's syndrome.

M K Connolly1

  • 1Department of Dermatology, University of California, San Francisco 94143-0517, USA. mkconnolly@orca.ucsf.edu

Seminars in Cutaneous Medicine and Surgery
|April 20, 2001
PubMed
Summary
This summary is machine-generated.

Sjogren's syndrome (SS) is an autoimmune condition causing dry eyes and mouth. Dermatologists should recognize its nonspecific skin symptoms to improve diagnosis and manage associated risks like vasculitis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

How do measurement duration and timing interact to influence estimation of basal physiological variables of a nocturnal rodent?

Comparative biochemistry and physiology. Part A, Molecular & integrative physiology·2014
Same author

Scleroderma gene expression and pathway signatures.

Current rheumatology reports·2008
Same author

Comparison of the reliability and validity of outcome instruments for cutaneous dermatomyositis.

The British journal of dermatology·2008
Same author

Dermatology position paper on the revision of the 1982 ACR criteria for systemic lupus erythematosus.

Lupus·2004
Same author

Aberrant serum hyaluronan and hyaluronidase levels in scleroderma.

The British journal of dermatology·2004
Same author

Dysregulation of transforming growth factor beta signaling in scleroderma: overexpression of endoglin in cutaneous scleroderma fibroblasts.

Arthritis and rheumatism·2002
Same journal

Systemic therapy for advanced cutaneous squamous cell carcinoma.

Seminars in cutaneous medicine and surgery·2019
Same journal

Atypical Fibroxanthoma.

Seminars in cutaneous medicine and surgery·2019
Same journal

Introduction, High-Risk Skin Cancer.

Seminars in cutaneous medicine and surgery·2019
Same journal

Emerging technologies for health information in dermatology: opportunities and drawbacks of web-based searches, social media, mobile applications, and direct-to-consumer genetic testing in patient care.

Seminars in cutaneous medicine and surgery·2019
Same journal

MoleMapper: an application for crowdsourcing mole images to advance melanoma early-detection research.

Seminars in cutaneous medicine and surgery·2019
Same journal

Digital imaging applications and informatics in dermatology.

Seminars in cutaneous medicine and surgery·2019
See all related articles

Area of Science:

  • Autoimmune diseases
  • Rheumatology
  • Dermatology

Background:

  • Sjogren's syndrome (SS) is a systemic autoimmune exocrinopathy targeting salivary and lacrimal glands.
  • It commonly presents as dry eyes (xerophthalmia) and dry mouth (xerostomia), often with arthritis.
  • SS can be primary or secondary to other rheumatic diseases like rheumatoid arthritis.

Purpose of the Study:

  • To highlight the significance of cutaneous manifestations in Sjogren's syndrome.
  • To emphasize the underrecognition and underdiagnosis of SS in dermatological practice.
  • To underscore the importance of dermatologists recognizing SS due to its prevalence and associated risks.

Main Methods:

  • Review of systemic manifestations of Sjogren's syndrome.
  • Analysis of cutaneous involvement frequency and characteristics.

Related Experiment Videos

  • Discussion of diagnostic challenges and clinical relevance for dermatologists.

    • Main Results:

    • Skin involvement occurs in approximately 50% of SS patients.
    • Cutaneous manifestations are often nonspecific (e.g., xerosis, pruritus) and less severe than other symptoms.
    • SS is frequently underrecognized by dermatologists due to nonspecific skin findings.

    Conclusions:

    • Dermatologists must be familiar with Sjogren's syndrome due to its high prevalence and significant systemic effects.
    • Early recognition of cutaneous signs can aid in diagnosing SS.
    • Awareness is crucial for managing risks of cutaneous vasculitis and lymphoproliferative disorders in SS patients.